Provention Bios Crohns Disease Drug Flunks MidStage Trial
The drug showed what the company is calling a substantial improvement in this symptomdriven score at the 12week point but it did not differentiate from placebo.
View ArticleProvention Bio wins PRIME designation for type 1 diabetes prevention drug
Meanwhile J&J partnered Crohn's drug flops in phase 2
View ArticleCapital Digestive Care and Physicians Endoscopy Launch New Practice Solutions...
New collaboration brings together leaders in digestive health with dedication to preserving the independence of gastroenterologists and advancing digestive healthcareCapital Digestive Care and...
View ArticleNew Plenity Pivotal Safety and Efficacy Data to be Presented at ObesityWeek 2019
Gelesis a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal GI tract today announced that the Company...
View ArticleHuman medicines European public assessment report EPAR Zessly infliximab...
Human medicines European public assessment report EPAR Zessly infliximab Arthritis PsoriaticPsoriasisCrohn DiseaseArthritis RheumatoidColitis UlcerativeSpondylitis Ankylosing Date of authorisation...
View ArticleCanadian Paper Pushes Back On Biosimilar Switching
A joint position statement published by originatorbacked bodies the Canadian Association of Gastroenterology and Crohns and Colitis Canada has expressed...&160;&160;
View ArticleGilead and Galapagos to Present New Data on Filgotinib at 2019 ACRARP Annual...
New analyses from filgotinib clinical development program reinforce the investigational medicines consistent efficacy and safety profile in the treatment of inflammatory diseasesGilead Sciences Inc....
View ArticleGlobal Stool Management Systems Market Size study by Application Pushed...
Global Stool Management Systems Market valued approximately USD XXX million in 2018 is anticipated to grow with a healthy growth rate of more than XXX over the forecast period 20192026. Stool...
View ArticleAntibiotic AddOn Active in Crohn's Disease
MedPage Today More evidence for a mycobacterial origin
View ArticleManagement of Crohn&x2019;s disease summary of updated NICE guidance
What you need to knowThis guideline update focuses on maintaining remission in people with ileocolonic Crohns disease who have had complete macroscopic resection within the last three monthsConsider...
View ArticlePodcast ACG 2019 Insights
MedPage Today SAN ANTONIO This year's American College of Gastroenterology meeting featured noteworthy presentations on topics such as functional bowel disease eosinophilic esophagitis and research in...
View ArticleOwlstone Medical to Contribute Breath Biopsy to 3TR the Largestever IMI2...
Largescale publicprivate research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment within and across seven different immunemediated diseases...
View ArticleSamsung Bioepis Enters into Commercialization Agreement for NextGeneration...
Agreement with Biogen covers Samsung Bioepis biosimilar candidates in preclinical and clinical development which reference two widelyused biologic medicines in ophthalmology ranibizumab and...
View ArticlePredictImmune and the Crohns & Colitis Foundation Announce Start of...
The study gets underway with the first patients recruited at New York UniversityBellevue the studys first site in the United StatesPredictImmune developers of pioneering prognostic tools for guiding...
View ArticleUniversity of Cincinnati finds new option for liver transplant patients
University of Cincinnati Budesonide a drug commonly used to treat Crohn's Disease may offer fewer side effects and work at least as well as prednisone as an antiorgan rejection medication in liver...
View ArticlePredictImmune to validate IBD test with Crohn's & Colitis Foundation
PredictImmune and the Crohn's & Colitis Foundation have agreed to work together to validate the PredictSure IBD test in patie More
View ArticleNew Data on Filgotinib in Rheumatoid Arthritis RA Demonstrate Durable...
Pooled Analysis from the FINCH RA Clinical Program with Investigational Filgotinib Reinforces Favorable Safety and Tolerability Profile Alone and in Combination with Methotrexate MTX or Conventional...
View ArticleNew data show noninferiority of efficacy for subcutaneous formulation of...
The results after switching from intravenous IV to subcutaneous SC treatment at Week 30 were comparable with that of maintaining CTP13 SC up to Week 54 up to Week 64 for safety profile1The study showed...
View ArticleInflammatory Bowel Disease Prevalence IBD in the United States
Source Centers for Disease Control and PreventionRelated MedlinePlus Pages Crohn's Disease Ulcerative Colitis
View ArticleCrohn's Disease May Not Be a Contraindication to Hemorrhoidectomy
Excisional hemorrhoidectomy may be a viable treatment option in patients with Crohn's disease who have failed nonoperative hemorrhoidal therapy according to a retrospective study. Reuters Health...
View Article